Journal of Microbiology and Biotechnology
The Korean Society for Microbiology and Biotechnology publishes the Journal of Microbiology and Biotechnology.
Journal of Microbiology and Biotechnology
Condition  Expression
When you enter More than two words, please use ‘and , or’ operation by means of putting ‘,(Comma Mark)’ between each word.

2016 ; 26(5): 876~882

AuthorJungman Kim, Robin Becina Guevarra, Son Giang Nguyen, Ji-Hoon Lee, Dong Kee Jeong, Tatsuya Unno
AffiliationFaculty of Biotechnology, College of Applied Life Science, SARI, Jeju National University, Jeju 63243, Republic of Korea
TitleEffects of the Antibiotics Growth Promoter Tylosin on Swine Gut Microbiota
PublicationInfo J. Microbiol. Biotechnol.2016 ; 26(5): 876~882
AbstractTylosin has been used as a livestock feed additive and antibiotic growth promoter for many years. However, the mode of action by which tylosin enhances animal growth is unclear. We used high-throughput sequencing of 16S rRNA genes to investigate the effects of tylosin as a feed additive on swine gut microbiota. No significant difference in the rate of weight increase was observed between control and tylosin-treated pigs during a 10-week feeding trial. However, tylosin-treated pigs showed rapid increases in the relative abundance of the phylum Firmicutes. Increases in Firmicutes species are associated with (so-called) obese-type gut microbiota. The abundance of species of four families of the phylum Firmicutes (Streptococcaceae, Peptococcaceae, Peptostreptococcaceae, and Clostridiaceae) correlated positively with host weight gain. The abundance of Streptococcaceae family bacteria was least affected by tylosin treatment. Distribution analysis of operational taxonomic units (OTUs) showed that both control and tylosin-treated pigs exhibited similar OTU alterations during growth. However, the tylosin-treated group showed distinctive alterations in gut microbiota when the host weighed approximately 60 kg, whereas similar alterations occurred at around 80 kg in the control group. Our results suggest that use of tylosin accelerates maturation of swine gut microbiota rather than altering its composition.
Full-Text(PDF)
Supplemental Data
Keywords16S rRNA gene, antibiotics, growth promoter, swine gut microbiota, tylosin
References
  1. Biddle AS, Black SJ, Blanchard JL. 2013. An in vitro model of the horse gut microbiome enables identification of lactate-utilizing bacteria that differentially respond to starch induction. PLoS One 8: e77599.
    Pubmed CrossRef Pubmed Central
  2. Blackwood RS, Tarara RP, Christe KL, Spinner A, Lerche NW. 2008. Effects of the macrolide drug tylosin on chronic diarrhea in rhesus macaques (Macaca mulatta). Comp. Med. 58: 81-87.
    Pubmed Pubmed Central
  3. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, et al. 2009. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 37:D141-D145.
    Pubmed CrossRef Pubmed Central
  4. Collier CT, Van der Klis JD, Deplancke B, Anderson DB, Gaskins HR. 2003. Effects of tylosin on bacterial mucolysis, Clostridium perfringens colonization, and intestinal barrier function in a chick model of necrotic enteritis. Antimicrob. Agents Chemother. 47: 3311-3317.
    Pubmed CrossRef Pubmed Central
  5. Cox LM, Blaser MJ. 2015. Antibiotics in early life and obesity. Nat. Rev. Endocrinol. 11: 182-190.
    Pubmed CrossRef Pubmed Central
  6. de Lange CFM, Pluske J, Gong J, Nyachoti CM. 2010. Strategic use of feed ingredients and feed additives to stimulate gut health and development in young pigs. Livestock Sci. 134: 124-134.
    CrossRef
  7. DiBaise JK, Frank DN, Mathur R. 2012. Impact of the gut microbiota on the development of obesity: current concepts. Am. J. Gastroenterol. Suppl. 1: 22-27.
    CrossRef
  8. Dibner JJ, Richards JD. 2005. Antibiotic growth promoters in agriculture: history and mode of action. Poult. Sci. 84: 634-643.
    Pubmed CrossRef
  9. Donoghue DJ. 2003. Antibiotic residues in poultry tissues and eggs: human health concerns? Poult. Sci. 82: 618-621.
    Pubmed CrossRef
  10. Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, Flint HJ. 2008. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. (Lond.) 32:1720-1724.
    Pubmed CrossRef
  11. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. 2011. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27: 2194-2200.
    Pubmed CrossRef Pubmed Central
  12. Frese SA, Parker K, Calvert CC, Mills DA. 2015. Diet shapes the gut microbiome of pigs during nursing and weaning. Microbiome 3: 28.
    Pubmed CrossRef Pubmed Central
  13. Gaggia F, Mattarelli P, Biavati B. 2010. Probiotics and prebiotics in animal feeding for safe food production. Int. J. Food Microbiol. 141: S15-S28.
    Pubmed CrossRef
  14. Holman DB, Chenier MR. 2013. Impact of subtherapeutic administration of tylosin and chlortetracycline on antimicrobial resistance in farrow-to-finish swine. FEMS Microbiol. Ecol. 85: 1-13.
    Pubmed CrossRef
  15. Jacela JY, DeRouchey JM, Tokach MD, Goodband RD, Nelssen JL, Renter DG, Dritz SS. 2010. Feed additives for swine: fact sheets-high dietary levels of copper and zinc for young pigs, and phytase. J. Swine Health Product. 18: 87-91.
  16. Jackson CR, Fedorka-Cray PJ, Barrett JB, Ladely SR. 2004. Effects of tylosin use on erythromycin resistance in enterococci isolated from swine. Appl. Environ. Microbiol. 70: 4205-4210.
    Pubmed CrossRef Pubmed Central
  17. Juntunen P, Heiska H, Olkkola S, Myllyniemi A-L, Hänninen M-L. 2010. Antimicrobial resistance in Campylobacter coli selected by tylosin treatment at a pig farm. Vet. Microbiol. 146: 90-97.
    Pubmed CrossRef
  18. Kallus SJ, Brandt LJ. 2012. The intestinal microbiota and obesity. J. Clin. Gastroenterol. 46: 16-24.
    Pubmed CrossRef
  19. Kalmokoff M, Waddington LM, Thomas M, Liang KL, Ma C, Topp E, et al. 2011. Continuous feeding of antimicrobial growth promoters to commercial swine during the growing/finishing phase does not modify faecal community erythromycin resistance or community structure. J. Appl. Microbiol. 110: 1414-1425.
    Pubmed CrossRef
  20. Kay P, Blackwell PA, Boxall AB. 2005. Column studies to investigate the fate of veterinary antibiotics in clay soils following slurry application to agricultural land. Chemosphere 60: 497-507.
    Pubmed CrossRef
  21. Kim HB, Borewicz K, White BA, Singer RS, Sreevatsan S, Tu ZJ, Isaacson RE. 2012. Microbial shifts in the swine distal gut in response to the treatment with antimicrobial growth promoter, tylosin. Proc. Natl. Acad. Sci. USA 109: 1548515490.
    CrossRef
  22. Kim J , Nguyen S G, G uevarra RB , Lee I, U nno T . 2015. Analysis of swine fecal microbiota at various growth stages. Arch. Microbiol. 197: 753-759.
    Pubmed CrossRef
  23. Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. 2013. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79: 5112-5120.
    Pubmed CrossRef Pubmed Central
  24. Krajmalnik-Brown R, Ilhan ZE, Kang DW, DiBaise JK. 2012. Effects of gut microbes on nutrient absorption and energy regulation. Nutr. Clin. Pract. 27: 201-214.
    Pubmed CrossRef Pubmed Central
  25. Lee KW, Ho Hong Y, Lee SH, Jang SI, Park MS, Bautista DA, et al. 2012. Effects of anticoccidial and antibiotic growth promoter programs on broiler performance and immune status. Res. Vet. Sci. 93: 721-728.
    Pubmed CrossRef
  26. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 102: 11070-11075.
    Pubmed CrossRef Pubmed Central
  27. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
    Pubmed CrossRef
  28. Marquardt RR, Jin LZ, Kim JW, Fang L, Frohlich AA, Baidoo SK. 1999. Passive protective effect of egg-yolk antibodies against enterotoxigenic Escherichia coli K88+ infection in neonatal and early-weaned piglets. FEMS Immunol. Med. Microbiol. 23: 283-288.
    Pubmed CrossRef
  29. Million M, Raoult D. 2013. The role of the manipulation of the gut microbiota in obesity. Curr. Infect. Dis. Rep. 15: 25-30.
    Pubmed CrossRef
  30. Moran CP, Shanahan F. 2014. Gut microbiota and obesity:role in aetiology and potential therapeutic target. Best Pract. Res. Clin. Gastroenterol. 28: 585-597.
    Pubmed CrossRef
  31. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F, et al. 2010. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59: 1635-1642.
    Pubmed CrossRef
  32. Norris V, Molina F, Gewirtz AT. 2013. Hypothesis: bacteria control host appetites. J. Bacteriol. 195: 411-416.
    Pubmed CrossRef Pubmed Central
  33. Pajarillo EA, Chae JP, Kim HB, Kim IH, Kang DK. 2015. Barcoded pyrosequencing-based metagenomic analysis of the faecal microbiome of three purebred pig lines after cohabitation. Appl. Microbiol. Biotechnol. 99: 5647-5656.
    Pubmed CrossRef
  34. Patterson J, Chapman T, Hegedus E, Barchia I, Chin J. 2005. Selected culturable enteric bacterial populations are modified by diet acidification and the growth promotant tylosin. Lett. Appl. Microbiol. 41: 119-124.
    Pubmed CrossRef
  35. Poole TL, Genovese KJ, Knape KD, Callaway TR, Bischoff KM, Nisbet DJ. 2003. Effect of subtherapeutic concentrations of tylosin on the inhibitory stringency of a mixed anaerobe continuous-flow culture of chicken microflora against Escherichia coli O157:H7. J. Appl. Microbiol. 94: 73-79.
    Pubmed CrossRef
  36. Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. 2013. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41: D590-D596.
    Pubmed CrossRef Pubmed Central
  37. Roura E, Homedes J, Klasing KC. 1992. Prevention of immunologic stress contributes to the growth-permitting ability of dietary antibiotics in chicks. J. Nutr. 122: 2383-2390.
    Pubmed
  38. Sanz Y, Santacruz A, De Palma G. 2008. Insights into the roles of gut microbes in obesity. Interdiscip. Perspect. Infect. Dis. 2008: 829101.
    Pubmed CrossRef Pubmed Central
  39. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. 2009. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75: 7537-7541.
    Pubmed CrossRef Pubmed Central
  40. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C, Hardt PD. 2010. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18: 190195.
    Pubmed CrossRef
  41. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. 2003. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13: 2498-2504.
    Pubmed CrossRef Pubmed Central
  42. Si W, Gong J, Tsao R, Zhou T, Yu H, Poppe C, et al. 2006. Antimicrobial activity of essential oils and structurally related synthetic food additives towards selected pathogenic and beneficial gut bacteria. J. Appl. Microbiol. 100: 296-305.
    Pubmed CrossRef
  43. Suchodolski JS, Dowd SE, Westermarck E, Steiner JM, Wolcott RD, Spillmann T, Harmoinen JA. 2009. The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing. BMC Microbiol. 9: 210.
    Pubmed CrossRef Pubmed Central
  44. Thacker PA. 2013. Alternatives to antibiotics as growth promoters for use in swine production: a review. J. Anim. Sci. Biotechnol. 4: 35.
    Pubmed CrossRef Pubmed Central
  45. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 10271031.
    Pubmed CrossRef
  46. Unno T. 2015. Bioinformatic suggestions on MiSeq-based microbial community analysis. J. Microbiol. Biotechnol. 25:765-770.
    Pubmed CrossRef
  47. Unno T, Kim JM, Guevarra RB, Nguyen SG. 2015. Effects of antibiotic growth promoter and characterization of ecological succession in swine gut microbiota. J. Microbiol. Biotechnol. 25: 431-438.
    Pubmed CrossRef
  48. Van Lunen TA. 2003. Growth performance of pigs fed diets with and without tylosin phosphate supplementation and reared in a biosecure all-in all-out housing system. Can. Vet. J. 44: 571-576.
    Pubmed Pubmed Central
  49. Walters WA, Xu Z, Knight R. 2014. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 588: 4223-4233.
    Pubmed CrossRef
  50. Zhang J, Kobert K, Flouri T, Stamatakis A. 2014. PEAR: a fast and accurate Illumina Paired-End reAd mergeR. Bioinformatics 30: 614-620.
    Pubmed CrossRef Pubmed Central
Copyright © 2009 by the Korean Society for Microbiology and Biotechnology.
All right reserved. Mail to jmb@jmb.or.kr
Online ISSN: 1738-8872    Print ISSN: 1017-7825    Powered by INFOrang.co., Ltd